menu search

HOTH / Why Hoth Therapeutics Shares Are Skyrocketing Today

Why Hoth Therapeutics Shares Are Skyrocketing Today
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic showed cognitive improvements in an Alzheimer's Disease (AD) mouse model. Hoth Therapeutics says all of the behavioral tests performed. Read More
Posted: Jul 12 2022, 11:42
Author Name: Benzinga
Views: 092067

HOTH News  

Why Is Hoth Therapeutics (HOTH) Stock Up 83% Today?

By InvestorPlace
June 6, 2023

Why Is Hoth Therapeutics (HOTH) Stock Up 83% Today?

Hoth Therapeutics (NASDAQ: HOTH ) stock is rocketing higher on Tuesday thanks to the company announcing positive results from a preclinical trial. Acc more_horizontal

Why Hoth Therapeutics Shares Are Nosediving - Hoth Therapeutics (NASDAQ:HOTH)

By Benzinga
December 30, 2022

Why Hoth Therapeutics Shares Are Nosediving - Hoth Therapeutics (NASDAQ:HOTH)

Hoth Therapeutics Inc HOTH shares are trading lower by 21.22% to $8.44 Friday morning after the company announced a $10 million private placement pric more_horizontal

Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program

By Benzinga
July 12, 2022

Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program

Hoth Therapeutics Inc (NASDAQ: HOTH) has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's dis more_horizontal

Why Hoth Therapeutics Shares Are Skyrocketing Today

By Benzinga
July 12, 2022

Why Hoth Therapeutics Shares Are Skyrocketing Today

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic sh more_horizontal

Hoth Therapeutics Adds New Pipeline Program For Stroke, Brain Injury

By Benzinga
April 19, 2022

Hoth Therapeutics Adds New Pipeline Program For Stroke, Brain Injury

Hoth Therapeutics Inc (NASDAQ: HOTH) has added a new asset, HT-TBI, as a novel, point-of-care therapy to treat secondary brain injury resulting from more_horizontal

Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?

By InvestorPlace
April 11, 2022

Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?

Hoth Therapeutics (HOTH) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT. The post Why Is Hoth Thera more_horizontal

Hoth Therapeutics' Novel Cancer Drug Prevented Cell Growth, Induced Cell Death Over 72 hours

By Benzinga
April 11, 2022

Hoth Therapeutics' Novel Cancer Drug Prevented Cell Growth, Induced Cell Death Over 72 hours

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are surging after announcing development updates for its novel cancer therapeutic, HT-KIT. Through a sp more_horizontal

Why Hoth Therapeutics Shares Are Rising

By Benzinga
April 11, 2022

Why Hoth Therapeutics Shares Are Rising

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 125.5% at $1.38 after the company said its mRNA frame-shifting therapeutic proved ef more_horizontal


Search within

Pages Search Results: